Home / Research / Publications / Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinomas identifies potential novel therapeutic options (PLENARY PRESENTATION)

Publications

Back

Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinomas identifies potential novel therapeutic options (PLENARY PRESENTATION)

March 2015

– Caris Life Sciences

Presentation

Study Design and Objective

Design: Retrospective review of HCC molecular profiling data generated by multiplatform analysis
Objective: To describe molecular patterns and associations, and potential novel therapeutic targets in HCC

Download Publication

Discover
More

Learn More

Ready to Get Started on the Journey?

Name(Required)

First Last

Company/Institution(Required)

Role/Title(Required)

Email(Required)

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Caris Life Sciences Exceeds 1,000 Published Studies Milestone

Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision Oncology Alliance

Publications

Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinomas identifies potential novel therapeutic options (PLENARY PRESENTATION)

Discover
More

Ready to Get Started on the Journey?

Caris Life Sciences Exceeds 1,000 Published Studies Milestone

Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision Oncology Alliance

Publications

Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinomas identifies potential novel therapeutic options (PLENARY PRESENTATION)

DiscoverMore

Spliceosome Mutations in Metastatic Breast Cancer An Analysis of a Decentralized Clinical Trial and Large Clinical Genomic Dataset

Molecular landscape of HR+/HER2- male breast cancer (MaBC) compared with female breast cancer (FeBC)

Ready to Get Started on the Journey?

Discover
More